Clinical trial

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

NCT05189535

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pentoxifylline Normalized identity: pentoxifyllineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-10-03

PhasePHASE2 / PHASE3

Conditions

Breast Cancer Femaleunresolved

Peripheral Neuropathyverified · MONDO: peripheral neuropathy

Interventions

PentoxifyllineDRUG · verified · RxNorm: pentoxifylline

PaclitaxelDRUG · verified · RxNorm: paclitaxel

PlaceboDRUG

Sponsors & collaborators

Ain Shams Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05189535 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.